Standout Papers

Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology 2006 2026 2012 2019 736
  1. Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology (2006)
    Rebecca Radde, Tristan Bolmont et al. EMBO Reports

Immediate Impact

2 by Nobel laureates 42 from Science/Nature 72 standout
Sub-graph 1 of 21

Citing Papers

The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
Emerging diagnostics and therapeutics for Alzheimer disease
2023 Standout
1 intermediate paper

Works of Simon Gengler being referenced

The Novel DA–CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APP SWE /PS1 ΔE9 Mouse Model
2018
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
2006 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Simon Gengler 864 455 260 438 11 1.4k
Hoau-Yan Wang 936 262 216 455 9 1.6k
Helen M. Melo 838 333 249 414 14 1.5k
Letícia Forny‐Germano 893 263 317 388 11 1.4k
Rebecca J. Griffin 757 342 186 501 8 1.5k
Zhongmin Xiang 764 355 140 528 23 1.6k
Juan Beauquis 572 372 170 251 30 1.4k
Patrick N. Pompl 637 211 117 331 8 1.1k
D. Blum‐Degen 610 262 172 298 11 1.1k
Robert Zöchling 441 511 126 491 10 1.3k
Yang Chang 1002 234 162 509 8 1.4k

All Works

Loading papers...

Rankless by CCL
2026